RGEN
Price:
$132.02
Market Cap:
$7.45B
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography column...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1986-04-29
Stock Exchange
NASDAQ
Ticker
RGEN
According to Repligen Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 145.08. This represents a change of -6.07% compared to the average of 154.46 of the last 4 quarters.
The mean historical PE Ratio of Repligen Corporation over the last ten years is 97.48. The current 145.08 PE Ratio has changed 14.78% with respect to the historical average. Over the past ten years (40 quarters), RGEN's PE Ratio was at its highest in in the March 2024 quarter at 1.14K. The PE Ratio was at its lowest in in the December 2023 quarter at -97.72.
Average
97.48
Median
126.23
Minimum
-312.91
Maximum
280.94
Discovering the peaks and valleys of Repligen Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 455.87%
Maximum Annual PE Ratio = 280.94
Minimum Annual Increase = -211.38%
Minimum Annual PE Ratio = -312.91
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 188.34 | -160.19% |
| 2024 | -312.91 | -211.38% |
| 2023 | 280.94 | 455.87% |
| 2022 | 50.54 | -55.54% |
| 2021 | 113.67 | -32.38% |
| 2020 | 168.10 | -20.04% |
| 2019 | 210.23 | 51.47% |
| 2018 | 138.79 | 183.09% |
| 2017 | 49.03 | -44.32% |
| 2016 | 88.06 | -12.85% |
The current PE Ratio of Repligen Corporation (RGEN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
52.12
5-year avg
64.11
10-year avg
97.48
Repligen Corporation’s PE Ratio is greater than Avantor, Inc. (-11.92), greater than Masimo Corporation (124.97), greater than Baxter International Inc. (-9.47), greater than AptarGroup, Inc. (20.36), greater than Bio-Rad Laboratories, Inc. (46.23), greater than DaVita Inc. (20.48), greater than Charles River Laboratories International, Inc. (-49.33), greater than Globus Medical, Inc. (18.21), greater than Stevanato Group S.p.A. (29.97),
| Company | PE Ratio | Market cap |
|---|---|---|
| -11.92 | $6.54B | |
| 124.97 | $9.42B | |
| -9.47 | $10.27B | |
| 20.36 | $7.68B | |
| 46.23 | $7.64B | |
| 20.48 | $13.34B | |
| -49.33 | $8.91B | |
| 18.21 | $10.69B | |
| 29.97 | $4.79B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repligen Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Repligen Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Repligen Corporation's PE Ratio?
How is the PE Ratio calculated for Repligen Corporation (RGEN)?
What is the highest PE Ratio for Repligen Corporation (RGEN)?
What is the 3-year average PE Ratio for Repligen Corporation (RGEN)?
What is the 5-year average PE Ratio for Repligen Corporation (RGEN)?
How does the current PE Ratio for Repligen Corporation (RGEN) compare to its historical average?